NorthWest Biotherapeutics Inc (NWBO)

[10baggerz]

Typing in capital letters doesn’t make you any less wrong.

I didn’t say it wouldn’t be a disaster if NWBO doesn’t meet their primary endpoint (I’m fairly sure they will meet OS). I also didn’t say that stocks don’t react negatively to failing to meet a primary endpoint.

I said that “failure to meet a primary endpoint doesn’t necessarily mean a failed trial.”

There are treatments that were approved after meeting secondary endpoints alone. Otherwise why even have secondary endpoints in the first place? I get that the primary endpoint is far more important and failure to meet the primary endpoint usually means a treatment will not meet the secondary endpoint or gain approval.